Giorgia Gollo,1 Gaia Savioli,2 Manuela Balocco,2 Cristina Venturino,3 Elio Boeri,4 Massimo Costantini,1 Gian Luca Forni21Regional Palliative Care Network, IRCCS AOU San Martino-IST, Genoa; 2Hematology, Center for Thalassemia, Galliera Hospital, Genoa, 3Psychiatric Service, Galliera Hospital, Genoa, 4Department of Hematology and Oncology, Gaslini Institute, Genoa, Italy Background: The prolonged survival of patients with thalassemia major as a result of the novel therapeutic strategies introduced in the last decade makes patient quality of life an important issue. This study investigated the changes occurring in overall quality of life in patients with thalassemia in the last decade.Methods: This was a population-based cross-sectional survey...
Background: In patients with β thalassaemia intermedia (TI), the milder anaemia and transfusion inde...
ABSTRACT In the present study, the aim was to explore the quality of life of thalassaemia major (TM)...
bjective: For adolescent thalassaemic patients, parenteral iron-chelation therapy is still a burden ...
Purpose: The aim of this study has been to evaluate the physical, psychological, and social well-bei...
Background and aims: Nowadays introduction of regular blood transfusion therapy has obviously improv...
Thalassemia is the most common hemoglobin disorder in the world and thalassemia major and intermedia...
Background With modern medical management, thalassemia major is now extending into adulthood and it ...
Background With modern medical management, thalassemia major is now extending into adulthood and it ...
Objective: To determine the problems faced by thalassemic patients in their personal, psychological ...
Background: Since the reduction of mental health in patients with Thalassemia may affect the quality...
Aims: The objective of this study was to determine the reliability and validity of the eight-item Sh...
β-thalassemia constitutes a major public health problem in the UAE and shows one of the highest carr...
Aims: The objective of this study was to determine the reliability and validity of the eight-item S...
CONTEXT AND OBJECTIVE Patients with beta-thalassemia major (β-TM) experience physical, psychological...
Background: Thalassemia as the most common genetic disorder worldwide is regarded as a serious probl...
Background: In patients with β thalassaemia intermedia (TI), the milder anaemia and transfusion inde...
ABSTRACT In the present study, the aim was to explore the quality of life of thalassaemia major (TM)...
bjective: For adolescent thalassaemic patients, parenteral iron-chelation therapy is still a burden ...
Purpose: The aim of this study has been to evaluate the physical, psychological, and social well-bei...
Background and aims: Nowadays introduction of regular blood transfusion therapy has obviously improv...
Thalassemia is the most common hemoglobin disorder in the world and thalassemia major and intermedia...
Background With modern medical management, thalassemia major is now extending into adulthood and it ...
Background With modern medical management, thalassemia major is now extending into adulthood and it ...
Objective: To determine the problems faced by thalassemic patients in their personal, psychological ...
Background: Since the reduction of mental health in patients with Thalassemia may affect the quality...
Aims: The objective of this study was to determine the reliability and validity of the eight-item Sh...
β-thalassemia constitutes a major public health problem in the UAE and shows one of the highest carr...
Aims: The objective of this study was to determine the reliability and validity of the eight-item S...
CONTEXT AND OBJECTIVE Patients with beta-thalassemia major (β-TM) experience physical, psychological...
Background: Thalassemia as the most common genetic disorder worldwide is regarded as a serious probl...
Background: In patients with β thalassaemia intermedia (TI), the milder anaemia and transfusion inde...
ABSTRACT In the present study, the aim was to explore the quality of life of thalassaemia major (TM)...
bjective: For adolescent thalassaemic patients, parenteral iron-chelation therapy is still a burden ...